Viking Therapeutics, Inc. (VKTX)
33.89
+0.51
(+1.53%)
USD |
NASDAQ |
Jan 22, 10:23
Viking Therapeutics Net Preferred Equity Issued (Purchased) (Quarterly)
Net Preferred Equity Issued (Purchased) (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Net Preferred Equity Issued (Purchased) (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Preferred Equity Issued (Purchased) (Quarterly) Benchmarks
| Eli Lilly & Co. | -- |
| Pfizer Inc. | -- |
| Amgen, Inc. | -- |
| Altimmune, Inc. | -- |
| Moderna, Inc. | -- |